However, as breast cancer is generally considered as a heterogeneous disease, the impact of physical activity may differ depending on the clinicopathologic features (e.g., tumor stage and hormone receptor status) and body composition (e.g., fat and skeletal muscle mass), eliciting diverse biological and molecular mechanisms and the varied and limited outcomes of breast cancer. The gene discussed is NR4A1; the disease is neoplasm.